MW073

MW073 is a serotonin 5-HT2B receptor antagonist which is used in scientific research. It is a highly selective antagonist of the serotonin 5-HT2B receptor. The drug is orally active in animals and is said to have a favorable drug-like profile. It produces antiaggressive effects without causing sedation or altering locomotor activity or anxiety in an animal model of Alzheimer's disease. Similarly, it produces neuroprotective, neurorestorative, and pro-cognitive-like effects in such models. MW073 was first described in the scientific literature by 2024. There is interest in MW073 for the potential treatment of Alzheimer's disease and other conditions.
== See also == List of investigational aggression drugs Minaprine
== References ==
Wikipedia contributors, "MW073", Wikipedia, revision 1372174635, retrieved 21 November 2026, source, CC BY-SA 4.0.